Department of Public Health and Clinical Medicine, Division of Occupational and Environmental Medicine/the OLIN unit, Umeå University, Umeå, Sweden.
Department of Health Sciences, Luleå University, Luleå, Sweden.
Clin Exp Allergy. 2017 Nov;47(11):1426-1435. doi: 10.1111/cea.12963. Epub 2017 Jul 12.
During the latter half of the 20th century, the prevalence of asthma and many other allergic diseases has increased. Information on asthma prevalence trends among adults after 2010, especially regarding studies separating allergic asthma from non-allergic asthma, is lacking.
The aim was to estimate prevalence trends of current asthma among adults, both allergic and non-allergic, from 1996 to 2016.
Three cross-sectional samples from the same area of Sweden, 20-69 years, participated in surveys with the same questionnaire in 1996 (n=7104 participants, 85% response rate), 2006 (n=6165, 77%) and 2016 (n=5466, 53%), respectively. Allergic rhino-conjunctivitis (ARC) was used as a marker for allergic sensitization to define allergic asthma.
The prevalence of current asthma increased from 8.4% (95% CI: 7.8-9.0) in 1996 to 9.9% (95% CI: 9.2-10.6) in 2006 and 10.9% (95% CI: 10.1-11.7) in 2016 (P<.001). Allergic asthma increased from 5.0% (95% CI: 4.5-5.5) in 1996 to 6.0% (95% CI: 5.4-6.6) in 2006 and further to 7.3% (95% CI: 6.6-8.0) in 2016 (P<.001), while the prevalence of non-allergic asthma remained stable around 3.4%-3.8%. The increase in current asthma was most pronounced among women and among the middle-aged. Physician-diagnosed asthma, asthma medication use and ARC also increased significantly, while the prevalence of symptoms common in asthma such as wheeze and attacks of shortness of breath decreased slightly or was stable. The prevalence of current smoking decreased from 27.4% in 1996 to 12.3% in 2016.
The prevalence of allergic asthma increased from 1996 to 2006 and further to 2016, while the prevalence of non-allergic asthma remained on a stable prevalence level. The prevalence of symptoms common in asthma decreased slightly or was stable despite a substantial decrease in the prevalence of current smoking. Clinicians should be aware that the previously observed increase in prevalence of allergic asthma is still ongoing.
在 20 世纪后半叶,哮喘和许多其他过敏性疾病的发病率有所增加。关于 2010 年后成年人哮喘发病率趋势的信息,尤其是关于将过敏性哮喘与非过敏性哮喘分开的研究,尚不清楚。
本研究旨在估计从 1996 年到 2016 年期间成年人(包括过敏性和非过敏性)的当前哮喘发病率趋势。
来自瑞典同一地区的三个横断面样本,年龄在 20-69 岁之间,分别于 1996 年(7104 名参与者,85%的应答率)、2006 年(6165 名,77%)和 2016 年(5466 名,53%)参加了相同问卷的调查。过敏性鼻炎-结膜炎(ARC)被用作过敏致敏的标志物,以定义过敏性哮喘。
当前哮喘的患病率从 1996 年的 8.4%(95%可信区间:7.8-9.0)上升到 2006 年的 9.9%(95%可信区间:9.2-10.6)和 2016 年的 10.9%(95%可信区间:10.1-11.7)(P<.001)。过敏性哮喘从 1996 年的 5.0%(95%可信区间:4.5-5.5)上升到 2006 年的 6.0%(95%可信区间:5.4-6.6),进一步上升到 2016 年的 7.3%(95%可信区间:6.6-8.0)(P<.001),而非过敏性哮喘的患病率保持在 3.4%-3.8%左右稳定。当前哮喘的发病率在女性和中年人群中最为明显。医生诊断的哮喘、哮喘药物使用和 ARC 也显著增加,而哮喘常见症状(喘息和呼吸急促发作)的患病率略有下降或保持稳定。当前吸烟的患病率从 1996 年的 27.4%下降到 2016 年的 12.3%。
从 1996 年到 2006 年,再到 2016 年,过敏性哮喘的患病率增加,而非过敏性哮喘的患病率保持稳定。尽管当前吸烟的患病率大幅下降,但哮喘常见症状的患病率略有下降或保持稳定。临床医生应注意到,先前观察到的过敏性哮喘患病率的增加仍在继续。